BSECompany Update1 Oct 2026 · 1 Oct 2026, 04:04 pm
Intimation of Disclosures
Evexia Lifecare Ltd · 524444
✦ AI SummaryPledge
Evexia Lifecare Ltd has received disclosure from Shree Saibaba Exim Private Limited, a promoter group entity, regarding the purchase of 66,25,997 equity shares of Evexia Lifecare Ltd on September 30, 2026. This disclosure is made under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern4/10
Regulatory Risk5/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Evexia Lifecare Ltd - 524444 - Disclosure Under Regulation 7(2)(A) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015 And Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011
Attachments (1)
📄pdf
Download →
8754a168-63e8-45ab-8af8-60fdcc12f3e7.pdf
View document text
EVEXIA LIFECARE LIMITED
(Formerly Known as Kavit Industries Ltd.)
Date: October 01, 2026
BSE Limited
P.]. Towers,
Dalal Street, Fort,
Mumbai- 400001
Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations,
2015
Dear Sir/Madam,
In accordance with the provisions of Regulation 7(2)(a) read with Regulation 6(2) of SEBI (Prohibition of
Insider Trading) Regulations, 2015, the Company has received disclosure on October 01, 2026 from M/s.
Shree Saibaba Exim Private Limited, Promoter Group with respect to the purchase of 66,25,997 equity
shares of Evexia Lifecare Limited.
Please find enclosed herewith necessary disclosure under Regulation 7(2)(a) read with Regulation 6(2) of
SEBI (Prohibition of Insider Trading) Regulations, 2015.
Please take the same on your record.
Thanking you.
Yours faithfully,
For, EVEXIA LIFECARE LI
MANAGING DIRECTOR
(DIN: 01631093)
Encl.: As Above
Reg. Off. : Tundav Anjesar Raod, Vill. Tundav, Tal.: Savli, Vadodara - 391 775
Corporate Office : 9th Floor, Galav Chambers, Sayajigunj, Vadodara-390 020. Ph : +91 265 2361100 /2200
CIN : L23100GJ1990PLC0O14692 Email : info@evexialifecare.com Web.: www.evexialifecare.com
Shree Saibaba Exim Private Limited
9 Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020
CIN - U51101GJ2013PTC077088
Email ID - shreesaibabaexim2022@gmail.com
Date: 01/10/2026
To, To,
The Department of Corporate Service, The Board of Directors,
BSE Limited, EVEXIA LIFECARE LIMITED,
Phiroze Jeejeebhoy Tower, Vill: Tundao, Tal: Salvi Vadodara-391775,
Dalal Street, Mumbai-400 001. Gujarat
Scrip Code: 524444
Dear Sir/Madam,
Subject: Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011
Thisi s with reference to the disclosure enclosed herewith as required to be made upon purchase of
shares of Evexia Lifecare Limited under Regulation 29(2) of SEBI (Substantial Acquisition of Shares
and Takeovers) Regulations, 2011.
Kindly take the above information on record.
Thanking you,
Yours faithfully,
Name: Shree Saibaba Exim Privit@Lisied
Through Artiben Jayeshbhai Thakkar
Director
(DIN: 02480296)
CC To:
EVEXIA LIFECARE LIMITED (For information and record)
Vill: Tundao, Tal: Salvi Vadodara-391775, Gujarat
Encl: as above
Annexure 1
Disclosures under Regulation 29(2) of SEBI (Substantial Acq n of Shares and Takeovers)
Regulation20s1,1
Name of the Target Company (TC) EVEXIA LIFECARE LIMITED
Name(s) of the acquirer/Seler and Persons Acting in | M/s. Shree Saibaba Exim Private Limited
Concert (PAC) with the acquirer/SeHer
Whether the acquirer/SeHer belongs to | Yes (Promoter Group)
Promoter/Promoter group
Name(s) of the Stock Exchange(s) where the shares of | BSE Limited
TC are Listed
Details of the acquisition / dispeset as follows Number % w.r.t. total % w.r.t.
share/voting total diluted
capital share/voting
wherever capital of
applicable(*) the TC (**)
Before the acquisition / dispesal under
consideration, holding of :
a) Shares carrying voting rights 12,75,49,827 6.794 % 6.794 %
b) Shares in the nature of encumbrance (pledge/ lien/
non-disposal undertaking/ others) 0 0.00% 0.00%
¢) Voting rights (VR) otherwise than by shares 0 0.00% 0.00%
d) Warrants/convertible securities/any other
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) 0 0.00% 0.00%
Total (a+b+c+d)
12,75,49,827 6.794 % 6.794 %
Details of acquisition/sale
a) Shares carrying voting rights acquired/seld 66,25,997 0.352% 0.352%
b) VRs acquired/sold otherwise than by shares 0 0.00% 0.00%
¢) Warrants/convertible securities/any other 0 0.00% 0.00%
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) acquired/sold
d) Shares encumbered / invoked/released by the 0 0.00% 0.00%
acquirer/seller
Total (a+b+ct+d)
66,25,997 0.352% 0.352%
After the acquisition/sale, holding of:
a) Shares carrying voting rights
b) Shares encumbered with the acquirer/seller 0 0.00% 0.00%
¢) VRs otherwise than by shares 0 0.00% 0.00%
d) Warrants/convertible securities/any other 0 0.00% 0.00%
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC (specify
holding in each category) after acquisition/sale
Total (a+b+c+d) 13,41,75,824 7.147% 7.147%
Mode of acquisition/sale (e.g. open market / eff-market | Open Market
bliei : f AT N /
inter-se-transfer etc.)
Date of acquisition / sale-ef-shares/—VR—er—date-of | September 30, 2026
p.o £ inti e £ alletment-of-sh 3 WhiCheVer
is applicable
Equity share capital / total voting capital of the TC | 187,73,28,995 representing 187,73,28,995 shares
before the said acquisition/sale of face value of Re. 1/- each.
Equity share capital/ total voting capital of the TC after | 187,73,28,995 representing 187,73,28,995 shares
the said acquisition/sale of face value of Re. 1/- each.
Total diluted share/voting capital of the TC after the | 187,73,28,995 representing 187,73,28,995 shares
said acquisition/sale of face value of Re. 1/- each.
Note:
(*)Total share capital/ voting capital to be taken as per the latest filing done by the company to the
Stock Exchange under Regulation 31 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations 2015
(**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion
of the outstanding convertible securities/warrants into equity shares of the TC.
Signature of the aci
Through Artiben Jayeshbhai Th:
Director
(DIN: 02480296)
Place: Vadodara
Date: October 01, 2026
Shree Saibaba Exim Private Limited
9 Floor, Galav Chambers, Opp. Sardar Patel Statute, Sayajigunj, Vadodara — 390020
CIN - U51101GJ2013PTC077088
Email ID - shreesaibabaexim2022@gmail.com
Date: October 01, 2026
Managing Director,
EVEXIA LIFECARE LIMITED,
Vill : Tundao, Tal: Salvi Vadodara- 391775, Gujarat
Scrip Code: 524444
Sub: Disclosure under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) Regulations,
2015.
Dear Sir/Madam,
This is with reference to the purchase of equity shares dated September 30, 2026.
This intimation is provided in terms of the provisions of Regulation 7(2)(a) of the SEBI Insider Trading
Regulations and all other applicable provisions of Securities and Exchange Board of India Act, 1992 and
applicable rules and regulations made thereunder.
This letter is intended for the Company’s information and records.
Thanking You.
Yours Faithfully,
Through Artiben Jayeshbhai Thakkar
Director
(DIN: 02480296)
Encl: As above
qejaoj
Wop9
runwej|
eu8a
roujo
eobms
dowde
|ynou)o
werya
nepa
3/dnq[
ro/iusy
exaJ
ys/dia
yaiaun e 031 / o werj N puya1- 5o neusj oI‘ asods )]E[
0T-T0-
odau
asad
7029
yrww
d0HWJ
5yosmenou £
(uae
yasneno
u9)z
-ounun
[sposm.
domdeuA: -
]NAETEWOT0E0O
c.iofiauu
qaow0jJ
y.ond-@osiS
WAunouap
ya3nenou
euuH
gadnmugas
eobmiap
SADNILR2S
Y3IP
qeja
dosieobmsipou
eobmsmouo
syexas‘ sdayA
yAdaoJ
pepno
yreuse
yAdaoJ
yuow
dpou
sadMUJ
euP%
,yAda
)401
)gnuy
)401J
syeray
esa/se
ojpiuB
syeras‘
meLe
djap8a
syexas‘
uis‘
meLe
)0UA91
ydaode
nou/
)0u49J
qagauJ
yuaove
naas‘
nou/
gqagauj
yrBys
Qia1s
nias‘
aunpa
-dqaesa
yr8ys
ruauq
sdapA
aunpa
rwauq 2™(
gbnuA |
9975'6
99'25'66
gnmwe
dbmwA
LE'HTL
7606-
syeta |
syero
s'8z¥
Z029
)0°€52
)L'TyL
%.mw/v‘\,
oJusip
,1pru Sy
(a3neno
TAIXIV
TIAIDVYTIWILAQ
Jmwu.:._auu oJ
.&eflefl
)ejaSoiA
saomunas
Y3IP
d1101.30
gaisou
eobmsinou
)giow0Jj e1/mwaw
LyAdaoJ
qau.oj
sadNuJ |
eup %%
diowoa
)40J
syera
yojpgu
diond/p
syqeras‘
esiduejs
peue
daisou/
)0uA91
qxapoJ
s/mruop
qaqau
nias‘
aepenae
ynSs
yo/ony31
dunpa
s0a(
wauyS 22(
g10w01
ybmA |
r7ug'4
yiond
syexo |
687/ )9'L6S )(
1quoymqin
erwa
ojsya
domde
u—.n..u
AIN‘
EPPI3SS
YXIW
ILABI9
qa1s‘
odd“ sefeli3nul‘
nleteJ
SXIW
0ZZOBW“
y na
yeru@‘
dVN‘
DIN/
d0U T
NYWT
y199
SEIqRq
yriwjap
YVLIS9800N
VAAYTSS
1001
)yeiu
geipeT
grem3s‘
AEpOpeIe -
€600Z0‘ g
LLLVELZ6T9
asseIqeqe
Bd 2 qe 0 er 2 Iq
Neua
:sy.2
,yyro
Syauqa
0112101
)a1N:
02+80
[Showing first 8,000 characters — download PDF for full document]